Founded
KANDO id: 366455

Corporate information

Registration country

Company type

Discoverer and developer of novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection.

Funding rounds

Profile Country
Sanderling Ventures


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials